DigestRedComo funciona
Red
/
Empresas
Ga
No verificado

Galderma Group AG

Sobre qué escribimos

CosméticaFarmacéuticaSaludSanidadVenta al público/Minorista

12 Comunicados de prensa

Ver todos los comunicados de prensa
14/11/2025
Biotecnología
Salud
Cosmética
Venta al público/Minorista
Farmacéutica
Galderma Completes Successful Placement of CHF 175 Million Bond
Fuente
Galderma Group AG
Editor
Business Wire
1.00
0
05/11/2025
Cosmética
Venta al público/Minorista
Salud
Higiene alimentaria
Sanidad
Farmacéutica
Biotecnología
Industria
Galderma Receives U.S. FDA Approval for Restylane® Lyft™ for the Enhancement of the Chin Profile
Fuente
Galderma Group AG
Editor
Business Wire
1.00
0
23/10/2025
Cosmética
Venta al público/Minorista
Farmacéutica
Salud
Web y redes sociales
Telefonía
Mercado de valores
Galderma Delivers Record Net Sales of 3.737 Billion USD in the First Nine Months of 2025 and 15.0% Year-on-Year Growth at Constant Currency, Raises Full-Year Guidance
Fuente
Galderma Group AG
Editor
Business Wire
1.00
0
01/07/2025
Sanidad
Salud
Cosmética
Venta al público/Minorista
Mercado laboral
Galderma Announces Departure of Its Chief Financial Officer
Fuente
Galderma Group AG
Editor
Business Wire
1.00
0
27/05/2025
Farmacéutica
Salud
Ir de compras
Lujo
Cosmética
Venta al público/Minorista
Sanidad
Finanzas
Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba
Fuente
Galderma Group AG
Editor
Business Wire
1.00
0
24/04/2025
Web y redes sociales
Telefonía
Mercado de valores
Farmacéutica
Salud
Ir de compras
Lujo
Cosmética
Venta al público/Minorista
Sanidad
Galderma Delivers Record First Quarter Net Sales of 1.129 Billion USD, Including Strong Performance From Two Launches With Blockbuster Potential, and Confirms Full-Year Guidance
Fuente
Galderma Group AG
Editor
Business Wire
1.00
0
17/04/2025
Industria
Biotecnología
Sanidad
Salud
Galderma launches new ALASTIN Restorative Skin Complex with Next Generation TriHex Technology®
Fuente
Galderma Group AG
Editor
Business Wire
1.00
0
21/03/2025
Sanidad
Salud
Cosmética
Venta al público/Minorista
Farmacéutica
Galderma Publishes its 2024 Annual Report and the Invitation to Its First Annual General Meeting
Fuente
Galderma Group AG
Editor
Business Wire
1.00
0
14/03/2025
Acciones y Obligaciones
Sanidad
Salud
Cosmética
Venta al público/Minorista
Farmacéutica
Galderma Successfully Placed an Inaugural EUR 500 Million Single Tranche Eurobond and New Dual Tranche CHF 435 Million CHF Bonds
Fuente
Galderma Group AG
Editor
Business Wire
1.00
0
06/03/2025
Web y redes sociales
Telefonía
Mercado de valores
Sanidad
Salud
Cosmética
Venta al público/Minorista
Farmacéutica
Galderma Delivers 2024 Record Net Sales of 4.410 Billion USD, up 9.3% Year-on-Year at Constant Currency1, and Record Core EBITDA of 1.031 Billion USD, While Preparing to Accelerate Its Growth Trajectory Into 2025 and Beyond
Fuente
Galderma Group AG
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0